A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma

NCT05736406 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Glioblastoma

Interventions

COMBINATION_PRODUCT: 5-ALA HCl intraoperative Photodynamic Therapy (PDT) at 200 J/cm^2
COMBINATION_PRODUCT: 5-ALA HCl intraoperative Photodynamic Therapy (PDT) at 400 J/cm^2

Sponsor

Hemerion Therapeutics